genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Dr.Reddy's Laborotories
Industry News
Teva Sells Actavis Generics Assets in U.K., Ireland
A-Lists
Top 25 Biotech Companies of 2016
Cancer
Dr. Reddy’s Buys Ex-Asia Rights to Eisai Cancer Candidate E7777
Industry News
Dr. Reddy’s Acquires U.S. Rights to XenoPort’s Phase III Psoriasis Candidate
A-Lists
Top 25 Biotech Companies of 2015
A-Lists
Top 25 Biotech Companies of 2014
Insights
No Passage to India
Cancer
Merck Serono Enters Biosimilar Segment in Deal with Dr. Reddy’s
Drug Discovery
Ranbaxy Launches Generic Lipitor in the U.S.
News
Fujifilm and Dr. Reddy’s Ink Pact Covering Generic Drugs in Japan
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
